Functional neuroimaging of the dopaminergic system using dopamine transporter SPECT (DAT) differentiates nigrostriatal dopamine loss from non-degenerative conditions such as essential tremor, drug-induced parkinsonism, dystonia or functional movement disorders. Here, SLC6A3 is linked to Parkinson disease.